Daniel J. Fernandes
Oprichter bij CharlestonPharma LLC
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Bradford Goodwin | M | 69 |
CharlestonPharma LLC
 CharlestonPharma LLC Medical SpecialtiesHealth Technology CharlestonPharma LLC develops therapeutic antibodies and related diagnostic tests for cancer patients and healthcare providers. It develops an obtained in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that specifically target nucleolin located in the plasma membrane and cytoplasm of tumor cells. The company was founded by Bradford S. Goodwin, Daniel J. Fernandes and Robert L. Capizzi in 2010 and is headquartered in Charleston, SC. | 14 jaar |
| Jon Olson | M | 61 |
Medical University of South Carolina
| - |
| Gordon Jones | M | - |
Medical University of South Carolina
| - |
| Gerard A. Silvestri | M | - |
Medical University of South Carolina
| - |
| Thomas A. Dix | M | - |
Medical University of South Carolina
| - |
| Jerry R. Youkey | M | 75 |
Medical University of South Carolina
| - |
| David E. Rivers | M | - |
Medical University of South Carolina
| 29 jaar |
| James C. Allen | M | - |
Medical University of South Carolina
| - |
| Routt Reigart | M | - |
Medical University of South Carolina
| - |
| Robert M. Sade | M | - |
Medical University of South Carolina
| - |
| Mark S. Sothmann | M | - |
Medical University of South Carolina
| - |
| David Pacitti | M | 58 |
Medical University of South Carolina
| - |
| Timothy Tremont | M | - |
Medical University of South Carolina
| - |
| Srini Srinivas | M | - |
Medical University of South Carolina
| - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Robert L. Capizzi | M | - |
CharlestonPharma LLC
CharlestonPharma LLC Medical SpecialtiesHealth Technology CharlestonPharma LLC develops therapeutic antibodies and related diagnostic tests for cancer patients and healthcare providers. It develops an obtained in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that specifically target nucleolin located in the plasma membrane and cytoplasm of tumor cells. The company was founded by Bradford S. Goodwin, Daniel J. Fernandes and Robert L. Capizzi in 2010 and is headquartered in Charleston, SC. | 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 15 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Daniel J. Fernandes
- Persoonlijk netwerk
